Breaking Calcutta News.Net - Calcutta News.Net
     
Home

Biocon launches anti-cancer drug in Abu Dhabi

Calcutta News.Net
Friday 10th October, 2008 (IANS)

Biocon Ltd, country's leading healthcare company, Friday said it has launched the cancer drug Abraxane in partnership with the Abu Dhabi-based pharmaceutical firm Neopharma in that Gulf nation.

Abraxane can be used for treatment of breast cancer after failure of a combination therapy for metastatic disease or relapse within six months of chemotherapy.

'The drug is going to change the way breast cancer is treated through chemotherapy as it is a combination of chemotherapy and a biotech formulation,' Biocon chairman and managing director Kiran Mazumdar-Shaw said in a statement.

'As it uses nanotechnology and a protein, it allows you to deliver a very cyto-toxic agent in a very targeted way to the tumour and will hence make a huge difference to cancer patients,' Shaw said in the statement.

Abraxane is approved for marketing in 35 countries and has several pending patent applications in India relating to it.

Email this story to a friend



Have your say on this story

Your name/nickname (optional)
Message
Image verification This is a captcha-picture. It is used to prevent mass-access by robots. (see: www.captcha.net)
(enter the verification code from the image above)


Top Stories  



RSS Feed